StockNews.com initiated coverage on shares of Zosano Pharma (NASDAQ:ZSAN – Get Rating) in a research note published on Monday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, BTIG Research downgraded shares of Zosano Pharma from a buy rating to a neutral rating in a research report on Wednesday, February 23rd. […]